EVO Visian ICL

Experience the freedom and flexibility of EVO Visian ICL
1 Million+ procedures performed worldwide

EVO Visian ICL

As Seen on Good Morning America!

Joe Jonas upgraded his vision with EVO Visian ICL!

“EVO ICL lens helped me to live life to the fullest with no more hesitation. I simply wake up and go about my day.”

– Joe Jonas

What is EVO Visian ICL™ and how does it work?

An ICL, also called an Implantable Collamer® Lens, is a refractive implant to correct common vision issues like myopia (nearsightedness) and astigmatism.

ICL’s are clear lenses that are surgically implanted to sit in front of the eye’s natural lens behind the iris, much in the same way that contact lenses sit on the cornea to reduce your dependency on glasses and contact lenses. ICLs function like contact lenses—except they work from within your eyes instead of sitting directly on their surface.

Unlike some other vision correction options, the EVO Visian ICL is an additive technology that corrects vision without the removal of any corneal tissue. The EVO Visian ICL is meant to reduce or eliminate the need for glasses or contacts. Unlike most permanent refractive solutions, EVO Visian ICL is removable.

EVO Visian ICL is made of Biocompatible Collamer Material that works in harmony with your eye. The procedure is painless with numbing eye drops and it typically takes less than 20 – 30 minutes. You can experience improved vision right away and a quick recovery time.

The procedure is completed in 3 simple steps:

Step 1
Dilating The Eyes

Your eye doctor will place eye drops in your eye to dilate (enlarge) the pupil in your eye.

Step 2
Numbing The Eyes

Once your pupil is fully dilated, your eye doctor will put numbing eye drops in your eye and ask you to lie on your back on the treatment chair.

Step 3
Insertion Of The EVO Visian ICL

Your eye doctor will create a small opening in your cornea that will be used to insert and position the EVO Visian ICL.

Joe Jonas Upgraded His Vision with EVO ICL!

If you have Myopia (Nearsightedness) or Astigmatism, you may qualify for EVO Visian ICL.

To be a EVO Visian ICL candidate, you must meet the following requirements:

  • Between 21 and 45 years old
  • No change in prescription within the last 12 months
  • Nearsighted with mild to severe myopia (-3D to -20D)
  • Looking for a procedure that can be reversed and does not create Dry Eye Syndrome

Conditions that can impact CLI candidacy include:

  • Pregnant or nursing. Women must wait at least three months after they stop breastfeeding before undergoing EVO Visian ICL.
  • Interior Chamber Depth (ACD) of < 3.0 mm
  • Anterior chamber angle less than Grade III as determined by gonioscopic examination
  • Not meeting minimum endothelial cell density

Take our Visian ICL Self-Test to learn more about your candidacy.

​​​​​​​Am I a EVO Visian ICL™ Candidate?

If you have Myopia (Nearsightedness) or Astigmatism, you may qualify for EVO Visian ICL.

To be a EVO Visian ICL candidate, you must meet the following requirements:

  • Between 21 and 45 years old
  • No change in prescription within the last 12 months
  • Nearsighted with mild to severe myopia (-3D to -20D)
  • Looking for a procedure that can be reversed and does not create Dry Eye Syndrome

Conditions that can impact CLI candidacy include:

  • Pregnant or nursing. Women must wait at least three months after they stop breastfeeding before undergoing EVO Visian ICL.
  • Interior Chamber Depth (ACD) of < 3.0 mm
  • Anterior chamber angle less than Grade III as determined by gonioscopic examination
  • Not meeting minimum endothelial cell density

Take our Visian ICL Self-Test to learn more about your candidacy.

Advantages of Visian ICL

  • Significant vision improvement
  • 99% patient satisfaction
  • Over 1 million procedures performed worldwide
  • Quick results
  • Can be removed if needed
  • Offers UV protection
  • Undetectable once in place
  • Can treat astigmatism and myopia
  • May be an option for patients who are not candidates for other vision correction procedures
  • Does not cause dry eye syndrome, which can be a side effect of other vision correction procedures​​​​
  • Provides excellent night vision

Frequently Asked Questions

Yes. The EVO Visian ICL™ received approval from the FDA for a wide range of myopic (nearsightedness) correction needs, with and without astigmatism. The EVO Visian ICL™ received FDA approval in 2005 to treat a wide range of myopia.

Yes. Anesthetic eye drops will be used to numb the eyes and there will be NO pain sensation during the procedure.

Extensive research and development preceded the introduction of the EVO Visian ICL™. It is now being used by more than 1,000,000 patients worldwide. The satisfaction rate among patients is extremely high – above 99%. The EVO Visian ICL™ provides unparalleled quality of vision and has excellent and stable outcomes for patients with mild to severe myopia. The EVO Visian ICL™ has been available internationally for over 20 years.

Although the lens is intended to remain in place permanently, a surgeon can remove the implant if necessary.

No. The EVO Visian ICL™ is positioned behind the iris (the colored part of the eye), where it is invisible to both you and observers.

The EVO Visian ICL™ is designed to be completely unobtrusive after it is put in place. It stays in position by itself and does not interact with any of the eye’s structures.

Feel free to contact us with any questions that you may have, or to Schedule Your Free Consultation to discover if the EVO Visian ICL™ is the right vision correction procedure for you.

The cost of the procedure depends on your prescription. The cost is all-inclusive, meaning the price will include the following:

  • Initial consultation
  • Follow-up visits and exams for one year
  • Enhancements if needed within one year


Manhattan LASIK Center offers affordable laser vision correction and Financing Options to make it easier to achieve clear vision. Are you ready to take the next step? Schedule your Free Consultation.

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.